Q4 2025 13F Holders as of 31 Dec 2025
-
Type / Class
-
Equity / Common stock, par value $.01 per share
-
Shares outstanding
-
8,133,373
-
Total 13F shares
-
3,418,588
-
Share change
-
+1,351,193
-
Total reported value
-
$3,863,003
-
Price per share
-
$1.13
-
Number of holders
-
21
-
Value change
-
+$1,409,923
-
Number of buys
-
12
-
Number of sells
-
7
Institutional Holders of Traws Pharma, Inc. - Common stock, par value $.01 per share (TRAW) as of Q4 2025
As of 31 Dec 2025,
Traws Pharma, Inc. - Common stock, par value $.01 per share (TRAW) was held by
21 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
3,418,588 shares.
The largest 10 holders included
ADAGE CAPITAL PARTNERS GP, L.L.C., Squadron Capital Management LLC, Ikarian Capital, LLC, ORBIMED ADVISORS LLC, BOOTHBAY FUND MANAGEMENT, LLC, ADAR1 Capital Management, LLC, VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, Seven Fleet Capital Management LP, and XTX Topco Ltd.
This page lists
21
institutional shareholders reporting positions in this security
for the Q4 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.